Readouts For TIGIT And Alzheimer’s Drugs Will Define Roche’s Year

Will Shape Growth Trajectory

 
• By Andrew McConaghie
Roche_Basel
Roche has more readouts this year and than any other European major pharma company. • Source: Alamy

More from Business

More from Scrip